Molecule
Lidocaine is an amide local anesthetic. It is available as injection, ointment and patches for infiltration, perineural and topical use. MedsAcross supplies Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
Source: US FDA prescribing information
Lidocaine HCl stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action.
Source: US FDA prescribing information
Table 1 (Recommended Dosages) summarizes the recommended volumes and concentrations of Xylocaine Injection for various types of anesthetic procedures. The dosages suggested in this table are for normal healthy adults and refer to the use of epinephrine-free solutions. When larger volumes are required, only solutions containing epinephrine should be used except in those cases where vasopressor drugs may be contraindicated. There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. Xylocaine is not approved for this use. These recommended doses serve only as a guide to the amount of anesthetic required for most routine procedures.
Source: US FDA prescribing information
Lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Source: US FDA prescribing information
XYLOCAINE INJECTIONS FOR INFILTRATION AND NERVE BLOCK SHOULD BE EMPLOYED ONLY BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES THAT MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED AND THEN ONLY AFTER ENSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY EQUIPMENT AND THE PERSONNEL NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES. DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH. Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use.
Source: US FDA prescribing information
Systemic Adverse experiences following the administration of lidocaine HCl are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage, rapid absorption or inadvertent intravascular injection, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature.
Source: US FDA prescribing information
Xylocaine® (lidocaine HCl Injection, USP) Product Code Unit of Sale Strength Each PRX480527 NDC 63323-485-26 Unit of 25 1% 200 mg per 20 mL (10 mg per mL) NDC 63323-485-41 20 mL Multiple Dose Vial PRX480627 NDC 63323-486-26 Unit of 25 2% 400 mg per 20 mL (20 mg per mL) NDC 63323-486-41 20 mL Multiple Dose Vial Xylocaine® -MPF (lidocaine HCl Injection, USP) Product Code Unit of Sale Strength Each PRX491227 NDC 63323-492-16 Unit of 25 1% 20 mg per 2 mL (10 mg per mL) NDC 63323-492-41 2 mL Single Dose Vial PRX491257 NDC 63323-492-36 Unit of 25 1% 50 mg per 5 mL (10 mg per mL) NDC 63323-492-43 5 mL Single Dose Vial PRX491237 NDC 63323-492-26 Unit of 25 1% 300 mg per 30 mL (10 mg per mL) NDC…
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
84 presentations of Lidocaine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Lidocaine 5% ointmentTopicalGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg/g patchCutaneousGeneric name | — | US FDA | Available on request |
| Lidocaine 100 mg/5 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/20 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 100 mg/5 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Lidocaine 500 mg/50 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg/5 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 1000 mg/50 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 700 mg patchTopicalGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/2 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 300 mg/30 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 40 mg/mL topical solutionTopicalGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/mL topical solutionOral, topicalGeneric name | — | US FDA | Available on request |
| Lidocaine 400 mg/20 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg/g patchTopicalGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/mL jellyTopicalGeneric name | — | US FDA | Available on request |
| Lidocaine 40 mg/2 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg/5 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Lidocaine 100 mg/10 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 100 mg/5 mL injectionEpidural, infiltration, intracaudalGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/10 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/2 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/mL oral solutionOralGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg/5 mL injectionEpidural, infiltration, intracaudalGeneric name | — | US FDA | Available on request |
| Lidocaine 250 mg/50 mL injectionInfiltration, intravenousGeneric name | — | US FDA | Available on request |
| Lidocaine Viscous 20 mg/mL topical solutionOral, topical | Hikma Pharmaceuticals | US FDA | Available on request |
| Xylocaine 200 mg/10 mL injectionInfiltration, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 100 mg/5 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Lidocaine 20 mg/mL solutionOropharyngealGeneric name | — | US FDA | Available on request |
| Lidocaine 250 mg/50 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 40 mg/mL oral solutionOralGeneric name | — | US FDA | Available on request |
| Xylocaine 200 mg/20 mL injectionInfiltration, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine 400 mg/20 mL injectionInfiltration, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 40 mg/2 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 50 mg/5 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Bondlido 200 mg transdermal systemTopical | MEDRx | US FDA | Available on request |
| Lidocaine 200 mg/20 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Lidocaine 2000 mg/250 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Lidocaine 40 mg/2 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 400 mg/20 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Xylocaine 1000 mg/50 mL injectionInfiltration, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine 500 mg/50 mL injectionInfiltration, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 20 mg/2 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 250 mg/50 mL injectionInfiltration | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 300 mg/30 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Akten 35 mg/mL ophthalmic gelOphthalmic | Thea Pharma | US FDA | Available on request |
| glydo 20 mg/mL jellyTopical | Sagent Pharmaceuticals | US FDA | Available on request |
| Lidocaine 200 mg/5 mL injectionRetrobulbar, topicalGeneric name | — | US FDA | Available on request |
| Lidocan 700 mg patchTopical | Puretek | US FDA | Available on request |
| Lidocaine 10 mg/1 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Lidocaine 1000 mg/50 mL injectionInfiltrationGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/1 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 20 mg/2 mL injectionInfiltrationGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/10 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/10 mL injectionInfiltrationGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/10 mL injectionEpidural, infiltrationGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/20 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 200 mg/5 mL injectionRetrobulbar, topical, transtrachealGeneric name | — | US FDA | Available on request |
| Lidocaine 2000 mg/500 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Lidocaine 300 mg/20 mL injectionEpidural, infiltration, intracaudal, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 300 mg/30 mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Lidocaine 40 mg/2 mL injectionEpidural, infiltrationGeneric name | — | US FDA | Available on request |
| Lidocaine 400 mg/20 mL injectionInfiltrationGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg patchCutaneousGeneric name | — | US FDA | Available on request |
| Lidocaine 50 mg/5 mL injectionInfiltrationGeneric name | — | US FDA | Available on request |
| Lidocan III 50 mg/g patchTopical | Puretek | US FDA | Available on request |
| Lidocan IV 50 mg/g patchTopical | Puretek | US FDA | Available on request |
| Lidocan V 50 mg/g patchTopical | Puretek | US FDA | Available on request |
| Lidocan VI 50 mg/g patchTopical | Puretek | US FDA | Available on request |
| Lidocan VII 50 mg/g patchTopical | Puretek | US FDA | Available on request |
| Lidoderm 700 mg patchTopical | TPU Pharma | US FDA | Available on request |
| Lidox 5 Patch 50 mg/g patchTopical | Injecta Medcial | US FDA | Available on request |
| Tridacaine III 50 mg/g patchTopical | Trifluent Pharma | US FDA | Available on request |
| Tridacaine XL 50 mg/g patchTopical | Trifluent Pharma | US FDA | Available on request |
| XYLOCAIN (LIDOCAINE HCl ) 500 mg/50 mL injectionInfiltration, perineural | HealthFirst | US FDA | Available on request |
| Xylocaine 250 mg/50 mL injectionInfiltration, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 100 mg/10 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 150 mg/10 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 200 mg/10 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| Xylocaine MPF 300 mg/20 mL injectionEpidural, infiltration, intracaudal, perineural | Fresenius Kabi | US FDA | Available on request |
| XYLOCAINE- MPF (LIDOCAINE HCl ) 100 mg/5 mL injectionEpidural, infiltration, intracaudal, perineural | HealthFirst | US FDA | Available on request |
| Ztlido 36 mg patchTopical | Scilex Pharmaceuticals | US FDA | Available on request |
| Lidocaine 10 mg/mL injectionInfiltration, perineuralGeneric name | — | US FDA | Available on request |
| Tridacaine II 50 mg/g patchTopical | Trifluent Pharma | US FDA | Available on request |
20 brand names across 1 markets.
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 19 November 1948 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Lidocaine in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 84 presentations of Lidocaine and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 20 brand names for Lidocaine, including Akten, Bondlido, glydo, Lidocaine Viscous, Lidocan, Lidocan III, Lidocan IV, Lidocan V.
Yes. The US FDA first approved Lidocaine on 19 November 1948, according to Drugs@FDA.
No listed presentation of Lidocaine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Lidocaine is classified under ATC code C01BB01 (Lidocaine).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.